To The Moon

Processa Pharmaceuticals CFO Russell Skibsted reported purchase of 1,984 common shares at USD 2.97.Skibsted’s direct holding rose to 4,308 common shares.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.

Ondas Inc. has announced changes to the compensation of two senior executives. Effective January 1, 2026, Neil Laird, the company's Chief Financial Officer and Treasurer, will receive an increased annual base salary of $375,000. Additionally, Laird has been awarded a one-time discretionary cash bonus of $200,000 for his performance during 2025. Patrick Huston, Chief Operating Officer, General Counsel, and Secretary, has been granted a one-time discretionary cash bonus of $50,000 for his performance from October 2025 through the end of the year.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ondas Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system